" class="no-js "lang="en-US"> Jacob Van Naarden Archives - Pharmtech Focus
Friday, January 27, 2023

Sort by:

Date

Top Post

ProPharma Acquires UK Based Digital Lab Consulting

ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]

Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform

Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and Foghorn Therapeutics […]

Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units

Eli Lilly and Company (NYSE: LLY) today announced executive leadership changes and the creation of neuroscience […]

Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses

Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and […]

  1. Kinnate Biopharma Adds Global Business and Oncology Expertise to Board of Directors Read more
  2. Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication Read more
  3. New AI Tool Makes Speedy Gene Editing Possible Read more
  4. European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease Read more
  5. Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome Read more